Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. A. Perdreau
Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis Following Treatment With Imatinib Mesylate
Cancer Research
Cancer Research
Oncology
Related publications
Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib
Endoscopy
Gastroenterology
Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated With Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review
OncoTargets and Therapy
Oncology
Pharmacology
RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor
Oncotarget
Oncology
A Case of Postoperative Recurrence of Peritoneal Dissemination Due to Gastrointestinal Stromal Tumor of the Ileum Responding to Imatinib Mesylate
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
Recurrent Gastrointestinal Stromal Tumor (GIST) of the Stomach Associated With a Novel C-Kit Mutation After Imatinib Treatment
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Sunitinib Malate for Gastrointestinal Stromal Tumour in Imatinib Mesylate–resistant Patients: Recommendations and Evidence
Current Oncology
Oncology
Imatinib Induced Severe Skin Reactions and Neutropenia in a Patient With Gastrointestinal Stromal Tumor
BMC Cancer
Cancer Research
Oncology
Genetics
Imatinib-Induced Hepatitis Treated by Corticosteroids in a Patient With Metastatic Gastrointestinal Stromal Tumor
Yeungnam University Journal of Medicine
Remarkable Response in a Case of Recurrent Gastrointestinal Stromal Tumor Treated With Low Dose Imatinib
Journal of Nihon University Medical Association
